(Q33209460)

23 July 2017

1 reference

title

Myoblast transplantation for inherited myopathies: a clinical approach (English)

1 reference

23 July 2017

0 references

Daniel Skuk

1

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Expert Opinion on Biological Therapy

23 July 2017

published in

1 reference

23 July 2017

volume

4

1 reference

23 July 2017

issue

12

1 reference

23 July 2017

page(s)

1871-1885

1 reference

The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Developmental Fate of Skeletal Muscle Satellite Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Localization of muscle gene products in nuclear domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Restricted distribution of mRNA produced from a single nucleus in hybrid myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Nuclear domains in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Transplanted primary neonatal myoblasts can give rise to functional satellite cells as identified using the Myf5nlacZl+ mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Satellite cell of skeletal muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Muscle-derived stem cells: characterization and potential for cell-mediated therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Formation of new muscle fibres and tumours after injection of cultured myogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Human myoblast transplantation: A simple assay for tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Muscle regeneration by bone marrow-derived myogenic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Invited review: myoblast transfer: a possible therapy for inherited myopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Arterial delivery of myoblasts to skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Myoblast transfer in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Human myoblast transplantation: preliminary results of 4 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Gene transfer into satellite cell from regenerating muscle: bupivacaine allows beta-Gal transfection and expression in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin-positive membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Resetting the Problem of Cell Death Following Muscle-Derived Cell Transplantation: Detection, Dynamics and Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Cellular and molecular reactions in mouse muscles after myoblast implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Contractile properties, structure and fiber phenotype of intact and regenerating slow-twitch muscles of mice treated with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Immunobiology of Cellular Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Transplantation of Human Myoblasts in SCID Mice as a Potential Muscular Model for Myotonic Dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Lymphocyte infiltration following allo-and xenomyoblast transplantation in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Cyclophosphamide immunosuppression does not permit successful myoblast allotransplantation in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

Evidence of fusion between host and donor myoblasts in skeletal muscle grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.12.1871

10.1517/14712598.4.12.1871

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference